Akari Therapeutics PLC (AKTX)
1.30
+0.06
(+4.84%)
USD |
NASDAQ |
Nov 22, 16:00
1.30
0.00 (0.00%)
After-Hours: 20:00
Akari Therapeutics Free Cash Flow: -14.84M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -14.84M |
| June 30, 2024 | -15.80M |
| March 31, 2024 | -15.60M |
| December 31, 2023 | -16.43M |
| September 30, 2023 | -20.60M |
| June 30, 2023 | -23.20M |
| March 31, 2023 | -23.51M |
| June 30, 2022 | -20.19M |
| March 31, 2022 | -16.48M |
| December 31, 2021 | -18.85M |
| September 30, 2021 | -18.08M |
| June 30, 2021 | -17.22M |
| March 31, 2021 | -16.63M |
| December 31, 2020 | -16.95M |
| September 30, 2020 | -16.18M |
| June 30, 2020 | -20.39M |
| March 31, 2020 | -20.89M |
| December 31, 2019 | -12.92M |
| September 30, 2019 | -14.22M |
| Date | Value |
|---|---|
| June 30, 2019 | -14.64M |
| March 31, 2019 | -18.15M |
| December 31, 2018 | -22.77M |
| September 30, 2018 | -26.53M |
| June 30, 2018 | -30.41M |
| March 31, 2018 | -26.83M |
| December 31, 2017 | -31.64M |
| September 30, 2017 | -29.62M |
| June 30, 2017 | -25.40M |
| March 31, 2017 | -26.37M |
| December 31, 2016 | -24.68M |
| September 30, 2016 | -24.90M |
| June 30, 2016 | -15.41M |
| March 31, 2016 | -10.42M |
| December 31, 2015 | -4.966M |
| September 30, 2015 | 1.137M |
| June 30, 2015 | 0.2132M |
| March 31, 2015 | -1.417M |
| December 31, 2014 | -1.477M |
Free Cash Flow Range, Past 5 Years
-23.51M
Minimum
Mar 2023
-12.92M
Maximum
Dec 2019
-18.04M
Average
-17.09M
Median
Free Cash Flow Benchmarks
| DBV Technologies SA | -108.72M |
| Ascendis Pharma AS | -- |
| Cellectis SA | 60.38M |
| Adaptimmune Therapeutics PLC | -56.05M |
| Biodexa Pharmaceuticals PLC | -11.12M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.49M |
| Cash from Financing (Quarterly) | -0.443M |
| Free Cash Flow Per Share (Quarterly) | -0.1222 |
| Free Cash Flow Yield | -139.5% |